A Research Study for Patients With Overactive Bladder

Completed · Phase 2 · Has a placebo group

Conditions studied: Overactive Bladder, Urinary Incontinence

In brief

The purpose of this study is to investigate whether injections of botulinum toxin Type A into the bladder are safe and effective in treating overactive bladder.

Key facts

Study ID

NCT00168454

Run by

Allergan

People needed

313

Starts

2005-07-01

Expected to finish

2008-06-01

Last updated by the study team

2013-11-06

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be between 18-85 years old
• Must have been diagnosed by his/her doctor with overactive bladder at least 6 months ago
• Must weigh at least 50 kg (110 lbs)
• Must be willing and able to record information regarding bladder function into a diary (provided)
• Must be willing and able to complete the entire course of the study

You may not qualify if…

• Cannot currently be catheterizing as a way to control incontinence
• Must not have used botulinum toxin type A or any other botulinum toxin previously for any condition

Where it is running

• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Ghent, Belgium
• Study site — Victoria, British Columbia, Canada
• Study site — Berlin, Germany
• Study site — Warsaw, Poland
• Study site — Sheffield, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.